Cargando…

Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?

Detalles Bibliográficos
Autores principales: Lai, Shih-Fan, Huang, Chiun-Sheng, Kuo, Sung-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797942/
https://www.ncbi.nlm.nih.gov/pubmed/35117076
http://dx.doi.org/10.21037/tcr.2018.11.18
_version_ 1784641675092557824
author Lai, Shih-Fan
Huang, Chiun-Sheng
Kuo, Sung-Hsin
author_facet Lai, Shih-Fan
Huang, Chiun-Sheng
Kuo, Sung-Hsin
author_sort Lai, Shih-Fan
collection PubMed
description
format Online
Article
Text
id pubmed-8797942
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87979422022-02-02 Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? Lai, Shih-Fan Huang, Chiun-Sheng Kuo, Sung-Hsin Transl Cancer Res Editorial AME Publishing Company 2019-03 /pmc/articles/PMC8797942/ /pubmed/35117076 http://dx.doi.org/10.21037/tcr.2018.11.18 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Editorial
Lai, Shih-Fan
Huang, Chiun-Sheng
Kuo, Sung-Hsin
Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
title Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
title_full Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
title_fullStr Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
title_full_unstemmed Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
title_short Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
title_sort whether adjuvant radiotherapy is desired for postmastectomy patients with t1–t2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797942/
https://www.ncbi.nlm.nih.gov/pubmed/35117076
http://dx.doi.org/10.21037/tcr.2018.11.18
work_keys_str_mv AT laishihfan whetheradjuvantradiotherapyisdesiredforpostmastectomypatientswitht1t2tumorsand13positiveaxillarylymphnodeswhoreceivedmodernsystemictherapy
AT huangchiunsheng whetheradjuvantradiotherapyisdesiredforpostmastectomypatientswitht1t2tumorsand13positiveaxillarylymphnodeswhoreceivedmodernsystemictherapy
AT kuosunghsin whetheradjuvantradiotherapyisdesiredforpostmastectomypatientswitht1t2tumorsand13positiveaxillarylymphnodeswhoreceivedmodernsystemictherapy